103 related articles for article (PubMed ID: 10925262)
1. Differential splicing of antigen-encoding RNA reduces endogenous epitope presentation that regulates the expansion and cytotoxicity of T cells.
Kienzle N; Buck M; Silins SL; Burrows SR; Moss DJ; Winterhalter A; Brooks A; Khanna R
J Immunol; 2000 Aug; 165(4):1840-6. PubMed ID: 10925262
[TBL] [Abstract][Full Text] [Related]
2. TCR alpha genes direct MHC restriction in the potent human T cell response to a class I-bound viral epitope.
Miles JJ; Borg NA; Brennan RM; Tynan FE; Kjer-Nielsen L; Silins SL; Bell MJ; Burrows JM; McCluskey J; Rossjohn J; Burrows SR
J Immunol; 2006 Nov; 177(10):6804-14. PubMed ID: 17082594
[TBL] [Abstract][Full Text] [Related]
3. Development of Epstein-Barr virus-specific memory T cell receptor clonotypes in acute infectious mononucleosis.
Silins SL; Cross SM; Elliott SL; Pye SJ; Burrows SR; Burrows JM; Moss DJ; Argaet VP; Misko IS
J Exp Med; 1996 Nov; 184(5):1815-24. PubMed ID: 8920869
[TBL] [Abstract][Full Text] [Related]
4. Peptide-MHC class I tetrameric complexes display exquisite ligand specificity.
Burrows SR; Kienzle N; Winterhalter A; Bharadwaj M; Altman JD; Brooks A
J Immunol; 2000 Dec; 165(11):6229-34. PubMed ID: 11086057
[TBL] [Abstract][Full Text] [Related]
5. A single specific amino acid residue in peptide antigens is sufficient to activate memory CTL: potential role of cross-reactive peptides in memory T cell maintenance.
Reali E; Guerrini R; Marastoni M; Tomatis R; Masucci MG; Traniello S; Gavioli R
J Immunol; 1999 Jan; 162(1):106-13. PubMed ID: 9886375
[TBL] [Abstract][Full Text] [Related]
6. In vivo cross-presentation of a soluble protein antigen: kinetics, distribution, and generation of effector CTL recognizing dominant and subdominant epitopes.
Nelson D; Bundell C; Robinson B
J Immunol; 2000 Dec; 165(11):6123-32. PubMed ID: 11086045
[TBL] [Abstract][Full Text] [Related]
7. Cutting edge: silencing virus-specific cytotoxic T cell-mediated immune recognition by differential splicing: a novel implication of RNA processing for antigen presentation.
Kienzle N; Sculley TB; Greco S; Khanna R
J Immunol; 1999 Jun; 162(12):6963-6. PubMed ID: 10358134
[TBL] [Abstract][Full Text] [Related]
8. Improved immunogenicity of an immunodominant epitope of the HER-2/neu protooncogene by alterations of MHC contact residues.
Vertuani S; Sette A; Sidney J; Southwood S; Fikes J; Keogh E; Lindencrona JA; Ishioka G; Levitskaya J; Kiessling R
J Immunol; 2004 Mar; 172(6):3501-8. PubMed ID: 15004150
[TBL] [Abstract][Full Text] [Related]
9. The immunodominant, Ld-restricted T cell response to hepatitis B surface antigen (HBsAg) efficiently suppresses T cell priming to multiple Dd-, Kd-, and Kb-restricted HBsAg epitopes.
Schirmbeck R; Stober D; El-Kholy S; Riedl P; Reimann J
J Immunol; 2002 Jun; 168(12):6253-62. PubMed ID: 12055239
[TBL] [Abstract][Full Text] [Related]
10. Cross-reactive memory T cells for Epstein-Barr virus augment the alloresponse to common human leukocyte antigens: degenerate recognition of major histocompatibility complex-bound peptide by T cells and its role in alloreactivity.
Burrows SR; Silins SL; Khanna R; Burrows JM; Rischmueller M; McCluskey J; Moss DJ
Eur J Immunol; 1997 Jul; 27(7):1726-36. PubMed ID: 9247584
[TBL] [Abstract][Full Text] [Related]
11. Competitive inhibition in vivo and skewing of the T cell repertoire of antigen-specific CTL priming by an anti-peptide-MHC monoclonal antibody.
Chung DH; Belyakov IM; Derby MA; Wang J; Boyd LF; Berzofsky JA; Margulies DH
J Immunol; 2001 Jul; 167(2):699-707. PubMed ID: 11441073
[TBL] [Abstract][Full Text] [Related]
12. The importance of exogenous antigen in priming the human CD8+ T cell response: lessons from the EBV nuclear antigen EBNA1.
Blake N; Haigh T; Shaka'a G; Croom-Carter D; Rickinson A
J Immunol; 2000 Dec; 165(12):7078-87. PubMed ID: 11120837
[TBL] [Abstract][Full Text] [Related]
13. The clonal composition of a peptide-specific oligoclonal CTL repertoire selected in response to persistent EBV infection is stable over time.
Levitsky V; de Campos-Lima PO; Frisan T; Masucci MG
J Immunol; 1998 Jul; 161(2):594-601. PubMed ID: 9670932
[TBL] [Abstract][Full Text] [Related]
14. HLA-B27 subtype polymorphism and CTL epitope choice: studies with EBV peptides link immunogenicity with stability of the B27:peptide complex.
Brooks JM; Colbert RA; Mear JP; Leese AM; Rickinson AB
J Immunol; 1998 Nov; 161(10):5252-9. PubMed ID: 9820497
[TBL] [Abstract][Full Text] [Related]
15. HIV-1 tat protein modulates the generation of cytotoxic T cell epitopes by modifying proteasome composition and enzymatic activity.
Gavioli R; Gallerani E; Fortini C; Fabris M; Bottoni A; Canella A; Bonaccorsi A; Marastoni M; Micheletti F; Cafaro A; Rimessi P; Caputo A; Ensoli B
J Immunol; 2004 Sep; 173(6):3838-43. PubMed ID: 15356131
[TBL] [Abstract][Full Text] [Related]
16. Enhanced antilymphoma efficacy of CD19-redirected influenza MP1-specific CTLs by cotransfer of T cells modified to present influenza MP1.
Cooper LJ; Al-Kadhimi Z; Serrano LM; Pfeiffer T; Olivares S; Castro A; Chang WC; Gonzalez S; Smith D; Forman SJ; Jensen MC
Blood; 2005 Feb; 105(4):1622-31. PubMed ID: 15507526
[TBL] [Abstract][Full Text] [Related]
17. A role for intercellular antigen transfer in the recognition of EBV-transformed B cell lines by EBV nuclear antigen-specific CD4+ T cells.
Taylor GS; Long HM; Haigh TA; Larsen M; Brooks J; Rickinson AB
J Immunol; 2006 Sep; 177(6):3746-56. PubMed ID: 16951335
[TBL] [Abstract][Full Text] [Related]
18. Changing patterns of dominant TCR usage with maturation of an EBV-specific cytotoxic T cell response.
Annels NE; Callan MF; Tan L; Rickinson AB
J Immunol; 2000 Nov; 165(9):4831-41. PubMed ID: 11046006
[TBL] [Abstract][Full Text] [Related]
19. Nonresponsiveness to an immunodominant Epstein-Barr virus-encoded cytotoxic T-lymphocyte epitope in nuclear antigen 3A: implications for vaccine strategies.
Schmidt C; Burrows SR; Sculley TB; Moss DJ; Misko IS
Proc Natl Acad Sci U S A; 1991 Nov; 88(21):9478-82. PubMed ID: 1719531
[TBL] [Abstract][Full Text] [Related]
20. Simian immunodeficiency virus evades a dominant epitope-specific cytotoxic T lymphocyte response through a mutation resulting in the accelerated dissociation of viral peptide and MHC class I.
Chen ZW; Craiu A; Shen L; Kuroda MJ; Iroku UC; Watkins DI; Voss G; Letvin NL
J Immunol; 2000 Jun; 164(12):6474-9. PubMed ID: 10843704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
